Using a swab inside the cheek and a sophisticated computer algorithm, a DNA test recently approved by federal regulators promises to assess genetic risk of opioid addiction. The test’s maker says ...
Neha Pathak, MD, FACP, DipABLM: Welcome to the WebMD Health Discovered Podcast. I'm Dr Neha Pathak, WebMD's, Chief Physician Editor for Health and Lifestyle Medicine. Many of us have talked to our ...
A new study questioned the clinical utility of an algorithm meant to predict opioid use disorder (OUD) risk based on 15 genetic variants. In a case-control analysis of more than 450,000 adults, the 15 ...
The FDA approved Journavx, the first new pain medication in over 20 years, as a non-opioid alternative for post-surgery pain. The drug, developed by Vertex Pharmaceuticals, blocks pain signals before ...
The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain relief that comes without the risk of addiction. It's a milestone after a long ...
Using a swab inside the cheek and a sophisticated computer algorithm, a DNA test recently approved by federal regulators promisesto assess genetic risk of opioid addiction. The test’s maker says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results